FDA approves pill which can prevent heart attack, stroke by reducing inflammation: How it works

The U.S. Food and Drug Administration (FDA) has made a major move in heart health care by approving Rybelsus, the first oral GLP-1 receptor agonist, which helps to manage cardiovascular risks. Up until now, Rybelsus was known as a diabetes…